PremiumThe FlyCatalyst Biosciences Inc trading resumes Catalyst Biosciences Inc trading halted, volatility trading pause Gyre Therapeutics 2.22M share Spot Secondary priced at $9.00 PremiumCompany AnnouncementsGyre Therapeutics Reports Q1 2025 Financial Results GYRE Earnings Report this Week: Is It a Buy, Ahead of Earnings? Gyre Therapeutics Highlights Fibrosis Treatment Strategy PremiumCompany AnnouncementsImpact of New U.S. Regulations on Gyre Therapeutics: Potential Delisting Risks and Investor Concerns Catalyst Biosciences Inc trading resumes Catalyst Biosciences Inc trading halted, volatility trading pause